1. Denosumab: ONJ and hypocalcaemia ADR updates in EU

   News item 20 September 2014 Pages: 1 - 1

2. Omeprazole + citalopram, escitalopram: drug interactions

   News item 20 September 2014 Pages: 2 - 2

3. Risk of QT prolongation with methadone

   News item 20 September 2014 Pages: 3 - 3

4. Rivastigmine-related ADRs reported to Lareb (Netherlands)

   News item 20 September 2014 Pages: 4 - 4

5. Updated EMA guidance on periodic safety update reports

   News item 20 September 2014 Pages: 5 - 5

6. Vancomycin: risk of SCARs

   News item 20 September 2014 Pages: 6 - 6

7. WEB-RADR: new social media project for ADR monitoring in EU

   Media release 20 September 2014 Pages: 7 - 7

8. EU Commission pharma policy change risky

   News item 20 September 2014 Pages: 8 - 8

9. Antidepressants, antipsychotics: QT prolongation and TdP

   Clinical study 20 September 2014 Pages: 9 - 9

10. Awareness during anaesthesia: NAP5 report released in UK

    News item 20 September 2014 Pages: 10 - 10

11. Benzodiazepines: higher risk of AD in Canadian elderly?

    Comment 20 September 2014 Pages: 11 - 11

12. Bevacizumab less costly, just as safe as ranibizumab in AMD

    News item 20 September 2014 Pages: 12 - 12

13. Liver injury from herbals and dietary supplements

    Clinical study 20 September 2014 Pages: 13 - 13

14. Abatacept

    Case report 20 September 2014 Pages: 14 - 14

15. Acenocoumarol

    Case report 20 September 2014 Pages: 15 - 15

16. Alendronic acid

    Case report 20 September 2014 Pages: 16 - 16

17. Allopurinol/azathioprine interaction

    Case report 20 September 2014 Pages: 17 - 17

18. Allopurinol/peginterferon-α-2b/ribavirin/telaprevir

    Case report 20 September 2014 Pages: 18 - 18

19. Amiodarone/methadone

    Case report 20 September 2014 Pages: 19 - 19

20. Amoxicillin

    Case report 20 September 2014 Pages: 20 - 20

21. Anakinra

    Case report 20 September 2014 Pages: 21 - 21

22. Antihypertensives

    Case report 20 September 2014 Pages: 22 - 22

23. Antineoplastics

    Case report 20 September 2014 Pages: 23 - 23

24. Asparaginase/dexamethasone/gemcitabine/oxaliplatin

    Case report 20 September 2014 Pages: 24 - 24

25. Aspirin/ketorolac

    Case report 20 September 2014 Pages: 25 - 25

26. Astragalus propinquus

    Case report 20 September 2014 Pages: 26 - 26

27. Atorvastatin

    Case report 20 September 2014 Pages: 27 - 27

28. Atracurium besilate/anaesthetics

    Case report 20 September 2014 Pages: 28 - 28

29. Azithromycin/ergotamine interaction

    Case report 20 September 2014 Pages: 29 - 29

30. Baclofen

    Case report 20 September 2014 Pages: 30 - 30

31. Bevacizumab

    Case report 20 September 2014 Pages: 31 - 31

32. Bevacizumab

    Case report 20 September 2014 Pages: 32 - 32

33. Bortezomib

    Case report 20 September 2014 Pages: 33 - 33

34. Bortezomib

    Case report 20 September 2014 Pages: 34 - 34

35. Bortezomib/cyclophosphamide

    Case report 20 September 2014 Pages: 35 - 35

36. Botulinum toxin A

    Case report 20 September 2014 Pages: 36 - 36

37. Botulinum toxin A

    Case report 20 September 2014 Pages: 37 - 37

38. Botulinum toxin A

    Case report 20 September 2014 Pages: 38 - 38

39. Buprenorphine/naloxone withdrawal

    Case report 20 September 2014 Pages: 39 - 39

40. Carbamazepine/sodium valproate

    Case report 20 September 2014 Pages: 40 - 40

41. Carboplatin/etoposide/topotecan

    Case report 20 September 2014 Pages: 41 - 41

42. Ceftaroline-fosamil

    Case report 20 September 2014 Pages: 42 - 42

43. Cetirizine

    Case report 20 September 2014 Pages: 43 - 43

44. Cetuximab

    Case report 20 September 2014 Pages: 44 - 44

45. Chemotherapeutic drugs

    Case report 20 September 2014 Pages: 45 - 45

46. Chemotherapy

    Case report 20 September 2014 Pages: 46 - 46

47. Chemotherapy

    Case report 20 September 2014 Pages: 47 - 47

48. Chlorhexidine

    Case report 20 September 2014 Pages: 48 - 48

49. Ciclosporin

    Case report 20 September 2014 Pages: 49 - 49

50. Ciclosporin/dexamethasone

    Case report 20 September 2014 Pages: 50 - 50